BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 29132990)

  • 1. Beneficiary characteristics and vaccinations in the end-stage renal disease Medicare beneficiary population, an analysis of claims data 2006-2015.
    Shen AK; Kelman JA; Warnock R; Zhang W; Brereton S; McKean S; Wernecke M; Chu S; Gellin BG
    Vaccine; 2017 Dec; 35(52):7302-7308. PubMed ID: 29132990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017.
    Shen AK; Warnock R; Selna W; MaCurdy TE; Chu S; Kelman JA
    Vaccine; 2019 Feb; 37(9):1194-1201. PubMed ID: 30683507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
    Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
    MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
    Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Bridges CB;
    MMWR Surveill Summ; 2016 Feb; 65(1):1-36. PubMed ID: 26844596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years.
    Black CL; Williams WW; Warnock R; Pilishvili T; Kim D; Kelman JA
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(27):728-733. PubMed ID: 28704347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.
    Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Fiebelkorn AP
    MMWR Surveill Summ; 2017 May; 66(11):1-28. PubMed ID: 28472027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza Vaccine Uptake and Missed Opportunities Among the Medicare-Covered Population With High-Risk Conditions During the 2018 to 2019 Influenza Season : A Retrospective Cohort Study.
    Cho BH; Weinbaum C; Tsai Y; Koppaka R
    Ann Intern Med; 2022 Jan; 175(1):1-10. PubMed ID: 34781717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved hepatitis B vaccination rates in ESRD patients in California.
    Brown J; Peters V
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S95-9. PubMed ID: 11053594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of standing-order policies with vaccination rates in dialysis clinics: a US-based cross-sectional study.
    Bond TC; Patel PR; Krisher J; Sauls L; Deane J; Strott K; Karp S; McClellan W
    Am J Kidney Dis; 2009 Jul; 54(1):86-94. PubMed ID: 19346041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.
    Taitel M; Cohen E; Duncan I; Pegus C
    Vaccine; 2011 Oct; 29(45):8073-6. PubMed ID: 21864625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Driving immunization through the Medicare Annual Wellness Visit: A growing opportunity.
    Shen AK; Warnock R; Kelman JA
    Vaccine; 2017 Dec; 35(50):6938-6940. PubMed ID: 29089193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine delivery and effectiveness in end-stage renal disease.
    Gilbertson DT; Unruh M; McBean AM; Kausz AT; Snyder JJ; Collins AJ
    Kidney Int; 2003 Feb; 63(2):738-43. PubMed ID: 12631142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
    Arya DP; Said MA; Izurieta HS; Perez-Vilar S; Zinderman C; Wernecke M; Alexander M; White T; Su IH; Lufkin B; MaCurdy T; Kelman J; Forshee R
    Vaccine; 2019 Oct; 37(43):6543-6549. PubMed ID: 31515146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination coverage among adults, excluding influenza vaccination - United States, 2013.
    Williams WW; Lu PJ; O'Halloran A; Bridges CB; Kim DK; Pilishvili T; Hales CM; Markowitz LE;
    MMWR Morb Mortal Wkly Rep; 2015 Feb; 64(4):95-102. PubMed ID: 25654611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination coverage and predictors of influenza, pneumococcal, herpes zoster, tetanus, measles, and hepatitis B vaccine uptake among adults in Greece.
    Tsiligianni I; Bouloukaki I; Papazisis G; Paganas A; Chatzimanolis E; Kalatharas M; Platakis I; Tirodimos I; Dardavesis T; Tsimtsiou Z
    Public Health; 2023 Nov; 224():195-202. PubMed ID: 37820537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient characteristics of Medicare beneficiaries who report not getting influenza and pneumococcal vaccinations, 2001-2013.
    Shen AK; Warnock R; Selna W; Chu S; Kelman JA
    Hum Vaccin Immunother; 2020 May; 16(5):1086-1092. PubMed ID: 31692400
    [No Abstract]   [Full Text] [Related]  

  • 17. Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
    Perez-Vilar S; Wernecke M; Arya D; Lo AC; Lufkin B; Hu M; Chu S; MaCurdy TE; Kelman J; Forshee RA
    Vaccine; 2019 Jun; 37(29):3856-3865. PubMed ID: 31122853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccination coverage estimates in the fee-for service Medicare beneficiary population 2006 - 2016: Using population-based administrative data to support a geographic based near real-time tool.
    Shen AK; Warnock R; Brereton S; McKean S; Wernecke M; Chu S; Kelman JA
    Hum Vaccin Immunother; 2018; 14(8):1848-1852. PubMed ID: 29641277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services.
    Willis BC; Ndiaye SM; Hopkins DP; Shefer A;
    MMWR Recomm Rep; 2005 Apr; 54(RR-5):1-11. PubMed ID: 15800472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of vaccinating providers reported through Medicare claims in office-based settings: Volume of influenza and pneumococcal vaccinations.
    Shen AK; Warnock R; Selna W; MaCurdy TE; Chu S; Kelman JA
    Vaccine; 2020 Jan; 38(1):15-19. PubMed ID: 31679862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.